The expanding pharmaceutical arsenal in the war on cancer
Author
Abstract
Suggested Citation
Download full text from publisher
Other versions of this item:
- Frank R. Lichtenberg, 2004. "The Expanding Pharmaceutical Arsenal in the War on Cancer," NBER Working Papers 10328, National Bureau of Economic Research, Inc.
References listed on IDEAS
- Frank Lichtenberg, 2005.
"The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001,"
International Journal of Health Economics and Management, Springer, vol. 5(1), pages 47-73, January.
- Frank R. Lichtenberg, 2003. "The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001," NBER Working Papers 9754, National Bureau of Economic Research, Inc.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Kyle, Margaret & Dubois, Pierre, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality," CEPR Discussion Papers 11487, C.E.P.R. Discussion Papers.
- Lakdawalla, Darius N. & Sun, Eric C. & Jena, Anupam B. & Reyes, Carolina M. & Goldman, Dana P. & Philipson, Tomas J., 2010.
"An economic evaluation of the war on cancer,"
Journal of Health Economics, Elsevier, vol. 29(3), pages 333-346, May.
- Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.
- Dolan, Paul & Metcalfe, Robert, 2012. "The relationship between innovation and subjective wellbeing," Research Policy, Elsevier, vol. 41(8), pages 1489-1498.
- Lionel Perrier & Magali Morelle & Nathalie Havet & Anthony Montella & Bertrand Favier & David Perol & Frédéric Gomez & Marie-Odile Carrere & Paul Rebattu, 2009.
"The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer,"
Working Papers
0903, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
- Lionel Perrier & Magali Morelle & Nathalie Havet & Anthony Montella & Bertrand Favier & David Pérol & Frédéric Gomez & Marie-Odile Carrère & Paul Rebattu, 2009. "The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer," Post-Print halshs-00371825, HAL.
- Martin, Stephen & Rice, Nigel & Smith, Peter C., 2008. "Does health care spending improve health outcomes? Evidence from English programme budgeting data," Journal of Health Economics, Elsevier, vol. 27(4), pages 826-842, July.
- Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2012. "I Farmaci Oncologici in Italia: innovazione e sostenibilità economica," Working Papers CERM 02-2012, Competitività, Regole, Mercati (CERM).
- Lichtenberg Frank R., 2008.
"Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data,"
Forum for Health Economics & Policy, De Gruyter, vol. 10(1), pages 1-27, March.
- Frank R. Lichtenberg, 2007. "Pharmaceutical Innovation and US Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data," NBER Chapters, in: Frontiers in Health Policy Research, Volume 10, National Bureau of Economic Research, Inc.
- Dubois, Pierre & Kyle, Margaret, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality Rates," TSE Working Papers 16-688, Toulouse School of Economics (TSE).
- Rosarin Sruamsiri & Dennis Ross-Degnan & Christine Y Lu & Nathorn Chaiyakunapruk & Anita K Wagner, 2015. "Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-17, March.
- Okunade, Albert A., 2004. "Concepts, measures, and models of technology and technical progress in medical care and health economics," The Quarterly Review of Economics and Finance, Elsevier, vol. 44(3), pages 363-368, July.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Margaret Oppenheimer & Helen LaVan & William Martin, 2015. "A Framework for Understanding Ethical and Efficiency Issues in Pharmaceutical Intellectual Property Litigation," Journal of Business Ethics, Springer, vol. 132(3), pages 505-524, December.
- Nebibe Varol & Joan Costa-i-Font & Alistair McGuire, 2011. "Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale," CESifo Working Paper Series 3459, CESifo.
- Bui, Thi Mai Van & Stolpe, Michael, 2007. "The impact of new drug launches on the loss of labor from disease and injury: evidence from German panel data," Kiel Working Papers 1317, Kiel Institute for the World Economy (IfW Kiel).
- Rodrigo R. Soares, 2005.
"Mortality Reductions, Educational Attainment, and Fertility Choice,"
American Economic Review, American Economic Association, vol. 95(3), pages 580-601, June.
- Rodrigo R. Soares, 2003. "Mortality Reductions, Educational Attainment, and Fertility Choice," Development and Comp Systems 0312006, University Library of Munich, Germany.
- Rodrigo R. Soares, 2004. "Mortality Reductions, Educational Attainment, and Fertility Choice," Econometric Society 2004 North American Winter Meetings 9, Econometric Society.
- Heuer, Alexander & Mejer, Malwina & Neuhaus, Jennifer, 2007. "The national regulation of pharmaceutical markets and the timing of new drug launches in Europe," Kiel Advanced Studies Working Papers 437, Kiel Institute for the World Economy (IfW Kiel).
- Papageorgiou, Chris & Savvides, Andreas & Zachariadis, Marios, 2007.
"International medical technology diffusion,"
Journal of International Economics, Elsevier, vol. 72(2), pages 409-427, July.
- Chris Papageorgiou & Andreas Savvides & Marios Zachariadis, 2005. "International Medical Technology Diffusion," University of Cyprus Working Papers in Economics 2-2005, University of Cyprus Department of Economics.
- Chris Papageorgiou & Andreas Savvides & Marios Zachariadis, 2006. "International Medical Technology Diffsion," 2006 Meeting Papers 23, Society for Economic Dynamics.
- Nebibe Varol & Joan Costa-Font & Alistair McGuire, 2012.
"Do International Launch Strategies of Pharmaceutical Corporations Respond to Changes in the Regulatory Environment?,"
Chapters, in: Alistair McGuire & Joan Costa-Font (ed.), The LSE Companion to Health Policy, chapter 12,
Edward Elgar Publishing.
- Varol, Nebibe & Costa-i-Font, Joan & McGuire, Alistair, 2010. "Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment?," LSE Research Online Documents on Economics 29972, London School of Economics and Political Science, LSE Library.
- Abdulkadir Civan & Michael Maloney, 2017. "Launch Decisions of Pharmaceutical Companies," Journal of Economics and Financial Analysis, Tripal Publishing House, vol. 1(1), pages 35-58.
- Giaccotto, Carmelo & Santerre, Rexford E & Vernon, John A, 2005. "Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry," Journal of Law and Economics, University of Chicago Press, vol. 48(1), pages 195-214, April.
- Charles I. Jones, 2016.
"Life and Growth,"
Journal of Political Economy, University of Chicago Press, vol. 124(2), pages 539-578.
- Charles I. Jones, 2011. "Life and Growth," NBER Working Papers 17094, National Bureau of Economic Research, Inc.
- Francesco Lancia & Giovanni Prarolo, 2012.
"A politico-economic model of aging, technology adoption and growth,"
Journal of Population Economics, Springer;European Society for Population Economics, vol. 25(3), pages 989-1018, July.
- Lancia, Francesco & Prarolo, Giovanni, 2007. "A Politico-Economic Model of Aging, Technology Adoption and Growth," Knowledge, Technology, Human Capital Working Papers 9552, Fondazione Eni Enrico Mattei (FEEM).
- F. Lancia & G. Prarolo, 2007. "A Politico-Economic Model of Aging, Technology Adoption and Growth," Working Papers 590, Dipartimento Scienze Economiche, Universita' di Bologna.
- Giovanni Prarolo & Francesco Lancia, 2007. "A Politico-Economic Model of Aging, Technology Adoption and Growth," Working Papers 2007.48, Fondazione Eni Enrico Mattei.
- Lichtenberg Frank R., 2010. "Pharmaceutical Price Discrimination and Social Welfare," Capitalism and Society, De Gruyter, vol. 5(1), pages 1-32, July.
- Muhammad Shahbaz & Muhammad Shafiullah & Mantu K. Mahalik, 2019.
"The dynamics of financial development, globalisation, economic growth and life expectancy in sub‐Saharan Africa,"
Australian Economic Papers, Wiley Blackwell, vol. 58(4), pages 444-479, December.
- Shahbaz, Muhammad & Shafiullah, Muhammad & Kumar, Mantu, 2019. "The Dynamics of Financial Development, Globalization, Economic Growth and Life Expectancy in Sub-Saharan Africa," MPRA Paper 96649, University Library of Munich, Germany, revised 20 Oct 2019.
- Melanie Büssgen & Tom Stargardt, 2023. "Does health technology assessment compromise access to pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 437-451, April.
- Frank R. Lichtenberg, 2007.
"Importation And Innovation,"
Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 16(6), pages 403-417.
- Frank R. Lichtenberg, 2006. "Importation and Innovation," NBER Working Papers 12539, National Bureau of Economic Research, Inc.
- repec:dau:papers:123456789/7972 is not listed on IDEAS
- John Vernon & Joseph Golec & J. Stevens, 2010. "Comparative Effectiveness Regulations and Pharmaceutical Innovation," PharmacoEconomics, Springer, vol. 28(10), pages 877-887, October.
- Saradindu Bhaduri & Thomas Brenner, 2013. "Examining the determinants of drug launch delay in pre-TRIPS India," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(5), pages 761-773, October.
- Zhou Yang & Donna B. Gilleskie & Edward C. Norton, 2009. "Health Insurance, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics," Journal of Human Resources, University of Wisconsin Press, vol. 44(1).
- Rodrigo R. Soares, 2007.
"On the Determinants of Mortality Reductions in the Developing World,"
Population and Development Review, The Population Council, Inc., vol. 33(2), pages 247-287, June.
- Rodrigo Reis Soares, 2006. "On the determinants of mortality reductions in the developing world," Textos para discussão 529, Department of Economics PUC-Rio (Brazil).
- Rodrigo R. Soares, 2007. "On the Determinants of Mortality Reductions in the Developing World," NBER Working Papers 12837, National Bureau of Economic Research, Inc.
- Chee-Ruey Hsieh & Ya-Ming Liu & Chia-Lin Chang, 2013.
"Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan,"
The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 287-295, April.
- Hsieh, Chee-Ruey & Liu, Ya-Ming & Chang, Chia-Lin, 2011. "Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan," MPRA Paper 35147, University Library of Munich, Germany.
More about this item
Keywords
Longevity; innovation; mortality; cancer; pharmaceuticals;All these keywords.
JEL classification:
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- J1 - Labor and Demographic Economics - - Demographic Economics
- O33 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Technological Change: Choices and Consequences; Diffusion Processes
NEP fields
This paper has been announced in the following NEP Reports:- NEP-HEA-2004-08-02 (Health Economics)
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:red:sed004:204. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christian Zimmermann (email available below). General contact details of provider: https://edirc.repec.org/data/sedddea.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.